Website search
UCL has sent 100 non-invasive breathing aids to India as part of the UK Government’s shipment of emergency medical supplies. The UCL-Ventura breathing aid is part of over 600 devices including ventilators and oxygen concentrators being sent to the country, which is experiencing its biggest surge in COVID-19 infections, with over 350,000 new cases reported
The UCL-Ventura, a low-cost breathing aid developed by UCL, UCLH and Mercedes-AMG High Performance Powertrains, is helping to cut deaths from COVID-19 in hospitals around the world. Reverse engineered and manufactured in record time at the start of the pandemic, when both ventilators and CPAPs were in short supply, the UCL-Ventura model has now been
Global University Venturing have released their latest podcast on tech transfer in a Talking Tech Transfer podcast featuring an in-depth conversation with UCLB’s CEO, Anne Lane. Anne shares her views with Global University Venturing’s editor, Thierry Heles on the importance of the UCL Technology Fund (UCLTF) and Apollo Therapeutics, the advantages of social enterprises and working with carmaker Mercedes on the CPAP
UCLB’s technology transfer experts supported the team behind a life-saving breathing device for COVID-19 patients to share its designs and manufacturing instructions with governments and healthcare providers across the world. Free-of-charge licences have been granted in over 100 countries via UCLB’s innovative e-licensing platform, making a global impact in the fight against the virus.
TenU, the association of ten world-leading US, UK and EU universities, will host a discussion on the development of entrepreneurial ecosystems and their role in post-COVID economic recovery, TenU Hosts Ecosystems.
Defaults to the text before the MORE tag or the first 55 words of the main content
Research England has awarded two grants, totalling £1.5 million, to support two programmes working to dramatically increase the economic value and social impacts derived from university research, both internationally and in the UK. The funds will be administered by the University of Cambridge. The grants, from the Research England Development (RED) Fund, support two programmes:
Defaults to the text before the MORE tag or the first 55 words of the main content
UCL Technology Fund (UCLTF), managed by AlbionVC in collaboration with UCL Business (UCLB), has funded UCL’s Cancer Institute in repurposing a sophisticated antibody engineering approach to research and develop a new treatment against Covid-19. The new project, led by Dr Martin Pule, Senior Lecturer in Haematology and Professor Kerry Chester, Department of Oncology, will investigate
Achilles Therapeutics was formed in October 2016 by Syncona Ltd and Cancer Research Technology, with the support of UCLB and the Francis Crick Institute. Stevenage, UK 29 May 2020 – Achilles Therapeutics (“Achilles”), a clinical stage biopharmaceutical company developing personalised cancer immunotherapies, today announced that it has dosed the first patient in a Phase I/II study